[1]
M. J. M. Ribeiro, “Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma”, Autops. Case Rep., vol. 8, no. 1, p. e2018005, Mar. 2018, doi: 10.4322/acr.2018.005.